19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
AHA News: For Kids, a Pandemic of Stress Could Have Long-Term Consequences6 Expert Tips for Defusing Kids' Quarantine MeltdownsFor Many Kids, Picky Eating Isn't Just a Phase, Study FindsSure-Fire Solutions for Managing Lockdown Temper TantrumsKeeping Kids Slim, Fit During Lockdown Isn't Easy: Here Are Some TipsCOVID-19 Antibodies May Tame Inflammatory Condition in Kids: StudyCould Certain Chemicals Trigger Celiac Disease?Italian Doctors Detail Cases of Inflammatory Condition in Kids With COVID-19AHA News: Is Your Child's Blood Pressure Something to Worry About?Zika Virus Tied to Profound Developmental DelaysCOVID-19 Still Rare in Kids, But Far From Harmless: StudyKids' ER Visits for Mental Health Problems Soared Over 10 YearsTo Prevent Injuries, Give Your Kids a Pass on Cutting the GrassFewer Kids in Cancer Trials, Which Might Not Be a Bad ThingLoving Family May Lower Future Depression Risk in KidsBest Ways to Help Kids Through the PandemicIn Rare Cases, COVID-19 May Be Causing Severe Heart Condition in KidsReplace That Old Carpet to Shield Your Kids From ToxinsCoronavirus Crisis Has Fewer Kids Getting Needed VaccinesAHA News: Traumatic Childhood Increases Lifelong Risk for Heart Disease, Early DeathFDA Bans Products That Help Kids Hide Vape Use From ParentsCalm Parenting Will Help Children Through Coronavirus PandemicStudy Confirms Safety, Effectiveness of Children's VaccinesUp to 50,000 U.S. Kids May Be Hospitalized With COVID-19 by Year's EndAre Immune-Compromised Kids at Greater Risk From COVID-19?All That Social Media Hasn't Hurt Kids' Social Skills, Study FindsKids of Mentally Ill Parents Have Higher Injury OddsSchool Closures Could Be Adding to Kids' WaistlinesU.S. Study Finds COVID-19 Seldom Severe in KidsWhy Your Kids' Playground Is Unsafe During COVID-19 PandemicSchool Closures Will Force Many U.S. Health Care Workers to Stay HomeGoing Easy on Yourself Is Key to Parenting Through the PandemicParents, Arm Your Kids Against COVID-19 With Good Hand-Washing HabitsToo Little Sleep Takes Toll on Kids' Mental Health: StudyU.S. Kids, Teens Eating Better But Nutrition Gaps PersistHow to Keep Housebound Kids Busy During a PandemicCalming Your Child's Coronavirus FearsAnother Study Finds COVID-19 Typically Mild for KidsSoap vs. Coronavirus: Best Hand-Washing Tips for You and Your KidsKids Get Mild COVID-19 Symptoms, But Chance of Transmission High: StudyWhen Chronic Pain Leads to Depression in KidsPost-Game Snacks May Undo Calorie-Burning Benefit of Kids' SportsPick Summer Camps Carefully When Your Kid Has Allergies, AsthmaKids Raised by Grandparents More Likely to Pile on Pounds: StudyKeep Your Kids Safe, Warm in Wintertime FunHow to Dispel Your Child's Fears About the New CoronavirusDiabetes Among U.S. Young, Especially Asians, Continues to ClimbMom-to-Be's Cosmetics Chemicals Could Lead to Heavier BabyMeds May Not Prevent Migraines in KidsAHA News: For Kids With Heart Defects, the Hospital Near Mom May Matter
Questions and AnswersVideosLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting

New Drug Combats Leading Cause of Dwarfism

HealthDay News
by -- Robert Preidt
Updated: Jun 21st 2019

new article illustration

FRIDAY, June 21, 2019 (HealthDay News) -- An experimental drug increased growth rates in children with dwarfism, according to a new study.

The four-year phase 2 trial was conducted at centers in the United States, France, United Kingdom and Australia, and included 35 children, ages 5-14, with the genetic bone disorder achondroplasia, the most common type of dwarfism.

The children were divided into four groups that received daily injections of the drug vosoritide, which helps regulate bone development, in increasing amounts.

The average increase in height among the children was about 2.4 inches a year, which is close to growth rates among children of average stature, according to the study published June 18 in the New England Journal of Medicine.

On average, the children's growth rate increased by 50%, said the authors of the study, which was designed and funded by drug maker BioMarin Pharmaceutical, which also analyzed the data.

The side effects of the drug were mostly mild, according to the researchers.

Vosoritide is now being tested in a phase 3 trial in a larger group of patients ages 5-18.

Achondroplasia is caused by overactivity of a signal that stops growth, which can be compared to overwatering a plant, explained study lead author Ravi Savarirayan, a clinical geneticist at Murdoch Children's Research Institute in Melbourne, Australia.

"This drug basically kinks the hose so that the plant gets the right amount of water and can resume regular growth," Savarirayan said in an institute news release.

Achondroplasia, which affects about 1 in every 25,000 infants, is caused by a mutation in the FGFR3 gene that impairs the growth of bones in the limbs, the spine and base of the skull.

Common complications among children with achondroplasia include spinal cord compression, spinal curvature and bowed legs. About half require spinal or other surgery.

"This study is the very first report of a possible disruptive, precision therapy for children with achondroplasia, which we hope will improve their health outcomes and functioning, as well as increase their height and access to their environment," Savarirayan said.

More information

The U.S. National Library of Medicine has more on achondroplasia.